Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 3, 2026
Response to Letter to the Editor Regarding 'Considerations on MRI-Based Stratification for Retreatment After TACE in HCC'
Weilang Wang, Yuan-Cheng Wang
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 5, 2026
Response to Letter to the Editor Regarding 'Practical Considerations for MRI-Derived Retreatment Response Scores in Viable HCC'
Weilang Wang, Yuan-Cheng Wang
Medical Physics
|
February 2, 2024
TPA: Two-stage progressive attention segmentation framework for hepatocellular carcinoma on multi-modality MRI
Lei Gao, Weilang Wang, Xiangpan Meng, et al.
Insights Into Imaging
|
August 1, 2025
Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma
Noble Chibuike Opara, Shuwei Zhou, Weilang Wang, et al.
The American Journal of Cardiology
|
November 20, 2023
Effects of Low-Osmolar Contrast Media on Long-Term Renal Impairment After Coronary Angiography: Iohexol Versus Iopromide
Ying Cui, Shuhang Zhang, Weilang Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 12, 2025
MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization
Weilang Wang, Xiuming Zhang, Yixing Yu, et al.
Journal of Gastroenterology and Hepatology
|
March 7, 2026
MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization
Shuhang Zhang, Weilang Wang, Wu Cai, et al.
Annals of Translational Medicine
|
January 25, 2021
MicroRNA-30/Cx43 axis contributes to podocyte injury by regulating ER stress in diabetic nephropathy
Min Li, Weijie Ni, Mengyu Zhang, et al.
Abdominal Radiology (New York)
|
January 10, 2024
Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis
Shuwei Zhou, Siyu Wang, Jian Xiang, et al.
Abdominal Radiology (New York)
|
April 11, 2025
The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization
Shuhang Zhang, Weilang Wang, Xiuming Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 3, 2026
Response to Letter to the Editor Regarding 'Considerations on MRI-Based Stratification for Retreatment After TACE in HCC'
Weilang Wang, Yuan-Cheng Wang
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 5, 2026
Response to Letter to the Editor Regarding 'Practical Considerations for MRI-Derived Retreatment Response Scores in Viable HCC'
Weilang Wang, Yuan-Cheng Wang
Medical Physics
|
February 2, 2024
TPA: Two-stage progressive attention segmentation framework for hepatocellular carcinoma on multi-modality MRI
Lei Gao, Weilang Wang, Xiangpan Meng, et al.
Insights Into Imaging
|
August 1, 2025
Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma
Noble Chibuike Opara, Shuwei Zhou, Weilang Wang, et al.
The American Journal of Cardiology
|
November 20, 2023
Effects of Low-Osmolar Contrast Media on Long-Term Renal Impairment After Coronary Angiography: Iohexol Versus Iopromide
Ying Cui, Shuhang Zhang, Weilang Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
December 12, 2025
MRI-Based Score to Predict Retreatment Response for Viable Hepatocellular Carcinomas After Transarterial Chemoembolization
Weilang Wang, Xiuming Zhang, Yixing Yu, et al.
Journal of Gastroenterology and Hepatology
|
March 7, 2026
MR Radiomics Combined With Radiologic Features to Predict Recurrence Location in Nonviable Hepatocellular Carcinoma After Transarterial Chemoembolization
Shuhang Zhang, Weilang Wang, Wu Cai, et al.
Annals of Translational Medicine
|
January 25, 2021
MicroRNA-30/Cx43 axis contributes to podocyte injury by regulating ER stress in diabetic nephropathy
Min Li, Weijie Ni, Mengyu Zhang, et al.
Abdominal Radiology (New York)
|
January 10, 2024
Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis
Shuwei Zhou, Siyu Wang, Jian Xiang, et al.
Abdominal Radiology (New York)
|
April 11, 2025
The nVR model: prediction of LI-RADS treatment response nonviable recurrence of hepatocellular carcinoma after primary transarterial chemoembolization
Shuhang Zhang, Weilang Wang, Xiuming Zhang, et al.
Page
of 2